

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 7.30523418 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.30523418 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 6.98994053 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.98994053 |
| 5 | omega-hydroxylase P450 pathway (GO:0097267) | 6.84861107 |
| 6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.75099255 |
| 7 | aromatic amino acid family catabolic process (GO:0009074) | 6.54826982 |
| 8 | indole-containing compound catabolic process (GO:0042436) | 5.89782205 |
| 9 | indolalkylamine catabolic process (GO:0046218) | 5.89782205 |
| 10 | tryptophan catabolic process (GO:0006569) | 5.89782205 |
| 11 | kynurenine metabolic process (GO:0070189) | 5.78990817 |
| 12 | high-density lipoprotein particle remodeling (GO:0034375) | 5.72207625 |
| 13 | urea metabolic process (GO:0019627) | 5.68310509 |
| 14 | urea cycle (GO:0000050) | 5.68310509 |
| 15 | bile acid biosynthetic process (GO:0006699) | 5.67439295 |
| 16 | alpha-linolenic acid metabolic process (GO:0036109) | 5.57076738 |
| 17 | tryptophan metabolic process (GO:0006568) | 5.55952871 |
| 18 | glyoxylate metabolic process (GO:0046487) | 5.48441020 |
| 19 | regulation of cholesterol esterification (GO:0010872) | 5.28477284 |
| 20 | negative regulation of fibrinolysis (GO:0051918) | 5.27606918 |
| 21 | cysteine metabolic process (GO:0006534) | 5.23030479 |
| 22 | nitrogen cycle metabolic process (GO:0071941) | 5.21430724 |
| 23 | oxidative demethylation (GO:0070989) | 5.18166919 |
| 24 | regulation of plasminogen activation (GO:0010755) | 5.17038017 |
| 25 | regulation of triglyceride catabolic process (GO:0010896) | 5.16612091 |
| 26 | regulation of fibrinolysis (GO:0051917) | 5.11221166 |
| 27 | protein carboxylation (GO:0018214) | 5.10669048 |
| 28 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.10669048 |
| 29 | sulfur amino acid catabolic process (GO:0000098) | 5.08547807 |
| 30 | reverse cholesterol transport (GO:0043691) | 5.06069572 |
| 31 | phospholipid efflux (GO:0033700) | 5.01321744 |
| 32 | complement activation, alternative pathway (GO:0006957) | 4.99380937 |
| 33 | regulation of protein activation cascade (GO:2000257) | 4.98342209 |
| 34 | bile acid metabolic process (GO:0008206) | 4.97228904 |
| 35 | protein-lipid complex remodeling (GO:0034368) | 4.93298978 |
| 36 | macromolecular complex remodeling (GO:0034367) | 4.93298978 |
| 37 | plasma lipoprotein particle remodeling (GO:0034369) | 4.93298978 |
| 38 | serine family amino acid catabolic process (GO:0009071) | 4.87918057 |
| 39 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.82606858 |
| 40 | aromatic amino acid family metabolic process (GO:0009072) | 4.75516927 |
| 41 | homocysteine metabolic process (GO:0050667) | 4.71491197 |
| 42 | triglyceride homeostasis (GO:0070328) | 4.70222050 |
| 43 | acylglycerol homeostasis (GO:0055090) | 4.70222050 |
| 44 | regulation of complement activation (GO:0030449) | 4.64683610 |
| 45 | ethanol metabolic process (GO:0006067) | 4.61974714 |
| 46 | tyrosine metabolic process (GO:0006570) | 4.61686380 |
| 47 | protein activation cascade (GO:0072376) | 4.60714778 |
| 48 | negative regulation of protein activation cascade (GO:2000258) | 4.56351129 |
| 49 | negative regulation of blood coagulation (GO:0030195) | 4.55055896 |
| 50 | negative regulation of hemostasis (GO:1900047) | 4.55055896 |
| 51 | drug catabolic process (GO:0042737) | 4.53221974 |
| 52 | amino-acid betaine metabolic process (GO:0006577) | 4.52173760 |
| 53 | bile acid and bile salt transport (GO:0015721) | 4.52053810 |
| 54 | lysine catabolic process (GO:0006554) | 4.48494608 |
| 55 | lysine metabolic process (GO:0006553) | 4.48494608 |
| 56 | alpha-amino acid catabolic process (GO:1901606) | 4.45875661 |
| 57 | * negative regulation of cholesterol transport (GO:0032375) | 4.45340287 |
| 58 | * negative regulation of sterol transport (GO:0032372) | 4.45340287 |
| 59 | plasma lipoprotein particle clearance (GO:0034381) | 4.40324856 |
| 60 | plasma lipoprotein particle assembly (GO:0034377) | 4.39910817 |
| 61 | cellular glucuronidation (GO:0052695) | 4.37036401 |
| 62 | * cholesterol efflux (GO:0033344) | 4.35818146 |
| 63 | phenylpropanoid metabolic process (GO:0009698) | 4.35557261 |
| 64 | cellular ketone body metabolic process (GO:0046950) | 4.30050437 |
| 65 | complement activation, classical pathway (GO:0006958) | 4.23878621 |
| 66 | positive regulation of lipoprotein lipase activity (GO:0051006) | 4.19482777 |
| 67 | positive regulation of triglyceride lipase activity (GO:0061365) | 4.19482777 |
| 68 | regulation of humoral immune response (GO:0002920) | 4.19147689 |
| 69 | coenzyme catabolic process (GO:0009109) | 4.18531158 |
| 70 | indolalkylamine metabolic process (GO:0006586) | 4.18148091 |
| 71 | acute-phase response (GO:0006953) | 4.17758442 |
| 72 | glutamate metabolic process (GO:0006536) | 4.16477493 |
| 73 | negative regulation of coagulation (GO:0050819) | 4.16337627 |
| 74 | glycine metabolic process (GO:0006544) | 4.16257702 |
| 75 | imidazole-containing compound metabolic process (GO:0052803) | 4.15586534 |
| 76 | regulation of bile acid biosynthetic process (GO:0070857) | 4.14282373 |
| 77 | very-low-density lipoprotein particle assembly (GO:0034379) | 4.12293823 |
| 78 | cellular amino acid catabolic process (GO:0009063) | 4.09926568 |
| 79 | complement activation (GO:0006956) | 4.09672194 |
| 80 | amine catabolic process (GO:0009310) | 4.07298736 |
| 81 | cellular biogenic amine catabolic process (GO:0042402) | 4.07298736 |
| 82 | S-adenosylmethionine metabolic process (GO:0046500) | 4.03944445 |
| 83 | negative regulation of wound healing (GO:0061045) | 4.03749967 |
| 84 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 4.03347015 |
| 85 | benzene-containing compound metabolic process (GO:0042537) | 4.01218633 |
| 86 | serine family amino acid metabolic process (GO:0009069) | 3.99307250 |
| 87 | flavonoid metabolic process (GO:0009812) | 3.99171655 |
| 88 | arginine metabolic process (GO:0006525) | 3.97622127 |
| 89 | low-density lipoprotein particle remodeling (GO:0034374) | 3.97163076 |
| 90 | protein-lipid complex assembly (GO:0065005) | 3.96687099 |
| 91 | positive regulation of blood coagulation (GO:0030194) | 3.95655594 |
| 92 | positive regulation of hemostasis (GO:1900048) | 3.95655594 |
| 93 | cellular modified amino acid catabolic process (GO:0042219) | 3.93905176 |
| 94 | positive regulation of lipid catabolic process (GO:0050996) | 3.93453383 |
| 95 | ethanol oxidation (GO:0006069) | 3.93030081 |
| 96 | * cholesterol homeostasis (GO:0042632) | 3.90612360 |
| 97 | serine family amino acid biosynthetic process (GO:0009070) | 3.88316608 |
| 98 | glucuronate metabolic process (GO:0019585) | 3.87781983 |
| 99 | uronic acid metabolic process (GO:0006063) | 3.87781983 |
| 100 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.85844223 |
| 101 | * sterol homeostasis (GO:0055092) | 3.84206723 |
| 102 | plasma lipoprotein particle organization (GO:0071827) | 3.82731014 |
| 103 | phospholipid homeostasis (GO:0055091) | 3.81096504 |
| 104 | regulation of cholesterol homeostasis (GO:2000188) | 3.79363535 |
| 105 | * intestinal cholesterol absorption (GO:0030299) | 3.78332049 |
| 106 | fibrinolysis (GO:0042730) | 3.77571300 |
| 107 | aldehyde catabolic process (GO:0046185) | 3.77314268 |
| 108 | lipoprotein metabolic process (GO:0042157) | 3.76500958 |
| 109 | negative regulation of lipase activity (GO:0060192) | 3.73172359 |
| 110 | alkaloid metabolic process (GO:0009820) | 3.73132380 |
| 111 | negative regulation of complement activation (GO:0045916) | 3.71957925 |
| 112 | ketone body metabolic process (GO:1902224) | 3.71735926 |
| 113 | exogenous drug catabolic process (GO:0042738) | 3.71715860 |
| 114 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.70079352 |
| 115 | cytolysis (GO:0019835) | 3.66592686 |
| 116 | drug metabolic process (GO:0017144) | 3.65438170 |
| 117 | regulation of apoptotic cell clearance (GO:2000425) | 3.63254454 |
| 118 | positive regulation of coagulation (GO:0050820) | 3.62438998 |
| 119 | organic acid catabolic process (GO:0016054) | 3.62334201 |
| 120 | carboxylic acid catabolic process (GO:0046395) | 3.62334201 |
| 121 | cofactor catabolic process (GO:0051187) | 3.61471793 |
| 122 | protein-lipid complex subunit organization (GO:0071825) | 3.61322390 |
| 123 | proline metabolic process (GO:0006560) | 3.61021526 |
| 124 | blood coagulation, intrinsic pathway (GO:0007597) | 3.60046018 |
| 125 | heme transport (GO:0015886) | 3.58990833 |
| 126 | short-chain fatty acid metabolic process (GO:0046459) | 3.55957072 |
| 127 | epoxygenase P450 pathway (GO:0019373) | 3.54349787 |
| 128 | drug transmembrane transport (GO:0006855) | 3.52930008 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.27706251 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.14595154 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.86482389 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.46006368 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.17120505 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.93541192 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.76580312 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.00721543 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.83174982 |
| 10 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.29062967 |
| 11 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.19728970 |
| 12 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.03553365 |
| 13 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.6227904 |
| 14 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.92998143 |
| 15 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.86805327 |
| 16 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.62618043 |
| 17 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.56820296 |
| 18 | GATA1_22025678_ChIP-Seq_K562_Human | 1.51206374 |
| 19 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.50772906 |
| 20 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.47186097 |
| 21 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.31902630 |
| 22 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.30148691 |
| 23 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.23873196 |
| 24 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.23109637 |
| 25 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.17133256 |
| 26 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.16670956 |
| 27 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.16189293 |
| 28 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.14844630 |
| 29 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.13259565 |
| 30 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.11854078 |
| 31 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.09207914 |
| 32 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.08332389 |
| 33 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.08183376 |
| 34 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.08038620 |
| 35 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.05784495 |
| 36 | VDR_22108803_ChIP-Seq_LS180_Human | 1.05405693 |
| 37 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.02266153 |
| 38 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.01130333 |
| 39 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.99588529 |
| 40 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.99496503 |
| 41 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.98293294 |
| 42 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.97617241 |
| 43 | TP53_16413492_ChIP-PET_HCT116_Human | 0.96632528 |
| 44 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.95723966 |
| 45 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.95570605 |
| 46 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.95118959 |
| 47 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.95118959 |
| 48 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.95012425 |
| 49 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.94161235 |
| 50 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.94150635 |
| 51 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.94063113 |
| 52 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.92466566 |
| 53 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.89187894 |
| 54 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.88329848 |
| 55 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.87953407 |
| 56 | * MYC_19829295_ChIP-Seq_ESCs_Human | 0.87015054 |
| 57 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.86524118 |
| 58 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.85177669 |
| 59 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.83997078 |
| 60 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.83779262 |
| 61 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.83594647 |
| 62 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.83547687 |
| 63 | STAT3_23295773_ChIP-Seq_U87_Human | 0.83542498 |
| 64 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.82627004 |
| 65 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.82627004 |
| 66 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.82231395 |
| 67 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.82231395 |
| 68 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.81034684 |
| 69 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.80679126 |
| 70 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.79854866 |
| 71 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.79568248 |
| 72 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.79441739 |
| 73 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.79097389 |
| 74 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.78718738 |
| 75 | * KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.77532239 |
| 76 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.77338671 |
| 77 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.77332887 |
| 78 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.76692409 |
| 79 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.76462533 |
| 80 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.76284133 |
| 81 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.76132982 |
| 82 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.75367587 |
| 83 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.74852672 |
| 84 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.74557292 |
| 85 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.74122390 |
| 86 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.73832552 |
| 87 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.73740799 |
| 88 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.73704061 |
| 89 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.73674631 |
| 90 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.73637739 |
| 91 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.73600344 |
| 92 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.73496281 |
| 93 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.73245930 |
| 94 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.72323235 |
| 95 | ETV1_20927104_ChIP-Seq_GIST48_Human | 0.71657048 |
| 96 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.70904274 |
| 97 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.68624841 |
| 98 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.68093307 |
| 99 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.67619350 |
| 100 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.67612430 |
| 101 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.67299280 |
| 102 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.64397531 |
| 103 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.64278078 |
| 104 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.62940223 |
| 105 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.61638187 |
| 106 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.61425394 |
| 107 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.61425394 |
| 108 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.61117529 |
| 109 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.60074165 |
| 110 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.58207815 |
| 111 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.57846410 |
| 112 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.57613522 |
| 113 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.57353933 |
| 114 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.57019011 |
| 115 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.56393021 |
| 116 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.54188018 |
| 117 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.53896064 |
| 118 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.53857114 |
| 119 | AR_20517297_ChIP-Seq_VCAP_Human | 0.52941098 |
| 120 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.51925406 |
| 121 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.51685447 |
| 122 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.50679774 |
| 123 | GATA2_19941826_ChIP-Seq_K562_Human | 0.50409768 |
| 124 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.50313789 |
| 125 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.49966106 |
| 126 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.49123228 |
| 127 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.49058962 |
| 128 | CBP_21632823_ChIP-Seq_H3396_Human | 0.49003540 |
| 129 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.47398482 |
| 130 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.47394860 |
| 131 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.46217203 |
| 132 | GATA1_19941826_ChIP-Seq_K562_Human | 0.45808539 |
| 133 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.45671919 |
| 134 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.43738118 |
| 135 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.43728462 |
| 136 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.43721646 |
| 137 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.43385893 |
| 138 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.43338005 |
| 139 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.42912314 |
| 140 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.42332373 |
| 141 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.41810235 |
| 142 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.38562972 |
| 143 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.38432764 |
| 144 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.38344832 |
| 145 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.37231468 |
| 146 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.37225566 |
| 147 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.36183325 |
| 148 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.35879676 |
| 149 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.35787531 |
| 150 | NCOR_22424771_ChIP-Seq_293T_Human | 0.35751857 |
| 151 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.35715928 |
| 152 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.35694566 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.40033581 |
| 2 | MP0005360_urolithiasis | 8.23528465 |
| 3 | * MP0005085_abnormal_gallbladder_physiolo | 6.18286279 |
| 4 | MP0005365_abnormal_bile_salt | 5.97788754 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.29840713 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.07635033 |
| 7 | MP0010329_abnormal_lipoprotein_level | 3.67087402 |
| 8 | * MP0003252_abnormal_bile_duct | 3.65218453 |
| 9 | MP0009840_abnormal_foam_cell | 3.57941312 |
| 10 | * MP0001666_abnormal_nutrient_absorption | 2.98228954 |
| 11 | MP0005083_abnormal_biliary_tract | 2.81463887 |
| 12 | MP0005332_abnormal_amino_acid | 2.69395215 |
| 13 | MP0003195_calcinosis | 2.58825199 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.24965568 |
| 15 | MP0004019_abnormal_vitamin_homeostasis | 2.23593678 |
| 16 | * MP0000609_abnormal_liver_physiology | 2.10787460 |
| 17 | * MP0002118_abnormal_lipid_homeostasis | 2.06554662 |
| 18 | MP0003868_abnormal_feces_composition | 1.80882153 |
| 19 | MP0002138_abnormal_hepatobiliary_system | 1.78387089 |
| 20 | MP0005319_abnormal_enzyme/_coenzyme | 1.78061975 |
| 21 | MP0009697_abnormal_copulation | 1.75326150 |
| 22 | MP0001764_abnormal_homeostasis | 1.62987979 |
| 23 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.50759600 |
| 24 | MP0005451_abnormal_body_composition | 1.49314549 |
| 25 | MP0003122_maternal_imprinting | 1.26296408 |
| 26 | MP0009643_abnormal_urine_homeostasis | 1.25249010 |
| 27 | MP0003705_abnormal_hypodermis_morpholog | 1.21684723 |
| 28 | MP0003011_delayed_dark_adaptation | 1.19497678 |
| 29 | MP0002254_reproductive_system_inflammat | 1.16008397 |
| 30 | * MP0000598_abnormal_liver_morphology | 1.10635259 |
| 31 | MP0003186_abnormal_redox_activity | 1.09515876 |
| 32 | MP0000604_amyloidosis | 1.04017666 |
| 33 | MP0009764_decreased_sensitivity_to | 1.02002481 |
| 34 | MP0002132_abnormal_respiratory_system | 1.01473589 |
| 35 | MP0005647_abnormal_sex_gland | 1.00174901 |
| 36 | MP0003879_abnormal_hair_cell | 0.98717905 |
| 37 | MP0009763_increased_sensitivity_to | 0.95561951 |
| 38 | MP0005084_abnormal_gallbladder_morpholo | 0.94794464 |
| 39 | MP0005636_abnormal_mineral_homeostasis | 0.90087228 |
| 40 | * MP0009642_abnormal_blood_homeostasis | 0.86474303 |
| 41 | MP0008469_abnormal_protein_level | 0.85158901 |
| 42 | MP0002876_abnormal_thyroid_physiology | 0.84439411 |
| 43 | MP0010368_abnormal_lymphatic_system | 0.82070087 |
| 44 | MP0009765_abnormal_xenobiotic_induced | 0.80314129 |
| 45 | MP0005408_hypopigmentation | 0.80221459 |
| 46 | MP0000566_synostosis | 0.78972612 |
| 47 | MP0003183_abnormal_peptide_metabolism | 0.78325258 |
| 48 | MP0002078_abnormal_glucose_homeostasis | 0.76405316 |
| 49 | * MP0005376_homeostasis/metabolism_phenot | 0.74100288 |
| 50 | MP0006036_abnormal_mitochondrial_physio | 0.73780768 |
| 51 | MP0002971_abnormal_brown_adipose | 0.73621723 |
| 52 | MP0001915_intracranial_hemorrhage | 0.72435361 |
| 53 | MP0002822_catalepsy | 0.71223362 |
| 54 | MP0009053_abnormal_anal_canal | 0.70107846 |
| 55 | MP0005448_abnormal_energy_balance | 0.70056374 |
| 56 | MP0002282_abnormal_trachea_morphology | 0.69932066 |
| 57 | * MP0003656_abnormal_erythrocyte_physiolo | 0.69759673 |
| 58 | MP0005670_abnormal_white_adipose | 0.68773947 |
| 59 | MP0005334_abnormal_fat_pad | 0.68715776 |
| 60 | MP0005220_abnormal_exocrine_pancreas | 0.62226435 |
| 61 | MP0005535_abnormal_body_temperature | 0.62032361 |
| 62 | MP0002168_other_aberrant_phenotype | 0.61123977 |
| 63 | MP0002089_abnormal_postnatal_growth/wei | 0.59646160 |
| 64 | MP0005551_abnormal_eye_electrophysiolog | 0.59054052 |
| 65 | MP0003690_abnormal_glial_cell | 0.58352326 |
| 66 | MP0004130_abnormal_muscle_cell | 0.57616133 |
| 67 | MP0003329_amyloid_beta_deposits | 0.57222001 |
| 68 | MP0001756_abnormal_urination | 0.56636507 |
| 69 | * MP0005266_abnormal_metabolism | 0.56541038 |
| 70 | MP0003123_paternal_imprinting | 0.55524372 |
| 71 | MP0006292_abnormal_olfactory_placode | 0.55428460 |
| 72 | MP0001986_abnormal_taste_sensitivity | 0.54878043 |
| 73 | MP0005187_abnormal_penis_morphology | 0.54490230 |
| 74 | MP0004264_abnormal_extraembryonic_tissu | 0.54230293 |
| 75 | MP0001661_extended_life_span | 0.53397476 |
| 76 | MP0000639_abnormal_adrenal_gland | 0.53067068 |
| 77 | MP0006035_abnormal_mitochondrial_morpho | 0.52528636 |
| 78 | MP0003718_maternal_effect | 0.52480943 |
| 79 | MP0002909_abnormal_adrenal_gland | 0.51143165 |
| 80 | MP0010234_abnormal_vibrissa_follicle | 0.50666749 |
| 81 | MP0003638_abnormal_response/metabolism_ | 0.50215418 |
| 82 | MP0002136_abnormal_kidney_physiology | 0.48770547 |
| 83 | MP0002249_abnormal_larynx_morphology | 0.47864262 |
| 84 | MP0005646_abnormal_pituitary_gland | 0.47205065 |
| 85 | MP0008872_abnormal_physiological_respon | 0.46680589 |
| 86 | MP0008873_increased_physiological_sensi | 0.45921325 |
| 87 | MP0005395_other_phenotype | 0.45280617 |
| 88 | MP0008874_decreased_physiological_sensi | 0.43584863 |
| 89 | MP0005379_endocrine/exocrine_gland_phen | 0.43042306 |
| 90 | MP0005409_darkened_coat_color | 0.42769106 |
| 91 | MP0002938_white_spotting | 0.42746702 |
| 92 | MP0002796_impaired_skin_barrier | 0.41780512 |
| 93 | MP0004782_abnormal_surfactant_physiolog | 0.41626939 |
| 94 | MP0003953_abnormal_hormone_level | 0.41546882 |
| 95 | MP0005410_abnormal_fertilization | 0.40760083 |
| 96 | MP0005248_abnormal_Harderian_gland | 0.40745525 |
| 97 | MP0005166_decreased_susceptibility_to | 0.39895702 |
| 98 | MP0003436_decreased_susceptibility_to | 0.39768858 |
| 99 | MP0004142_abnormal_muscle_tone | 0.37724115 |
| 100 | MP0009780_abnormal_chondrocyte_physiolo | 0.37259047 |
| 101 | MP0009115_abnormal_fat_cell | 0.37009538 |
| 102 | MP0003172_abnormal_lysosome_physiology | 0.36890757 |
| 103 | * MP0005464_abnormal_platelet_physiology | 0.36516531 |
| 104 | MP0002928_abnormal_bile_duct | 0.36404965 |
| 105 | MP0005666_abnormal_adipose_tissue | 0.36358651 |
| 106 | MP0005058_abnormal_lysosome_morphology | 0.35382743 |
| 107 | MP0003075_altered_response_to | 0.35203812 |
| 108 | MP0003724_increased_susceptibility_to | 0.35129343 |
| 109 | MP0000579_abnormal_nail_morphology | 0.34911406 |
| 110 | MP0005164_abnormal_response_to | 0.33584328 |
| 111 | MP0009384_cardiac_valve_regurgitation | 0.33455054 |
| 112 | MP0000230_abnormal_systemic_arterial | 0.33319760 |
| 113 | MP0000249_abnormal_blood_vessel | 0.32794308 |
| 114 | MP0005377_hearing/vestibular/ear_phenot | 0.32427746 |
| 115 | MP0003878_abnormal_ear_physiology | 0.32427746 |
| 116 | MP0001324_abnormal_eye_pigmentation | 0.31996849 |
| 117 | MP0003633_abnormal_nervous_system | 0.31653670 |
| 118 | MP0004147_increased_porphyrin_level | 0.31479035 |
| 119 | MP0001944_abnormal_pancreas_morphology | 0.31471548 |
| 120 | MP0001881_abnormal_mammary_gland | 0.31443775 |
| 121 | MP0004043_abnormal_pH_regulation | 0.30500140 |
| 122 | MP0001243_abnormal_dermal_layer | 0.30199098 |
| 123 | MP0006082_CNS_inflammation | 0.30051244 |
| 124 | MP0000538_abnormal_urinary_bladder | 0.29817989 |
| 125 | MP0009672_abnormal_birth_weight | 0.29356693 |
| 126 | MP0004883_abnormal_blood_vessel | 0.28730108 |
| 127 | MP0002160_abnormal_reproductive_system | 0.28336093 |
| 128 | MP0002837_dystrophic_cardiac_calcinosis | 0.28288817 |
| 129 | MP0001845_abnormal_inflammatory_respons | 0.28185191 |
| 130 | MP0002970_abnormal_white_adipose | 0.27145516 |
| 131 | MP0005167_abnormal_blood-brain_barrier | 0.26926503 |
| 132 | MP0003300_gastrointestinal_ulcer | 0.26414316 |
| 133 | MP0001853_heart_inflammation | 0.26032293 |
| 134 | MP0002135_abnormal_kidney_morphology | 0.23993305 |
| 135 | MP0003943_abnormal_hepatobiliary_system | 0.22927025 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.22127500 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 7.21437472 |
| 3 | Deep venous thrombosis (HP:0002625) | 7.13422453 |
| 4 | Hypobetalipoproteinemia (HP:0003563) | 7.01870195 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.70427923 |
| 6 | Xanthomatosis (HP:0000991) | 6.34503929 |
| 7 | Prolonged partial thromboplastin time (HP:0003645) | 6.32673194 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.39688982 |
| 9 | Hypolipoproteinemia (HP:0010981) | 5.07447830 |
| 10 | Complement deficiency (HP:0004431) | 4.96774444 |
| 11 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.71137205 |
| 12 | Epidermoid cyst (HP:0200040) | 4.60742650 |
| 13 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.58328263 |
| 14 | Hyperammonemia (HP:0001987) | 4.58307298 |
| 15 | Joint hemorrhage (HP:0005261) | 4.50100937 |
| 16 | Fat malabsorption (HP:0002630) | 4.35065861 |
| 17 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.29826509 |
| 18 | Abnormality of the common coagulation pathway (HP:0010990) | 4.28821514 |
| 19 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.22372941 |
| 20 | Hyperglycinemia (HP:0002154) | 4.18637905 |
| 21 | Conjugated hyperbilirubinemia (HP:0002908) | 4.18390578 |
| 22 | Hypoalphalipoproteinemia (HP:0003233) | 4.16921302 |
| 23 | Ketosis (HP:0001946) | 4.16743993 |
| 24 | Hyperglycinuria (HP:0003108) | 4.11279785 |
| 25 | Abnormality of methionine metabolism (HP:0010901) | 4.08288062 |
| 26 | Abnormality of glycine metabolism (HP:0010895) | 3.98454102 |
| 27 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.98454102 |
| 28 | Hypoglycemic coma (HP:0001325) | 3.82394170 |
| 29 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.80970605 |
| 30 | Abnormality of the intrinsic pathway (HP:0010989) | 3.63523134 |
| 31 | Abnormality of complement system (HP:0005339) | 3.62448930 |
| 32 | Hyperbilirubinemia (HP:0002904) | 3.41224793 |
| 33 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.37678696 |
| 34 | * Hypercholesterolemia (HP:0003124) | 3.37433264 |
| 35 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.29331359 |
| 36 | Acanthocytosis (HP:0001927) | 3.20495684 |
| 37 | Abnormality of nucleobase metabolism (HP:0010932) | 3.13324861 |
| 38 | Steatorrhea (HP:0002570) | 3.03134561 |
| 39 | Delayed CNS myelination (HP:0002188) | 3.00861112 |
| 40 | Ketoacidosis (HP:0001993) | 3.00472079 |
| 41 | Myocardial infarction (HP:0001658) | 2.89159418 |
| 42 | Abnormality of serum amino acid levels (HP:0003112) | 2.88434880 |
| 43 | Hepatocellular carcinoma (HP:0001402) | 2.87316432 |
| 44 | Spontaneous abortion (HP:0005268) | 2.85871561 |
| 45 | Metabolic acidosis (HP:0001942) | 2.85849749 |
| 46 | Skin nodule (HP:0200036) | 2.81724936 |
| 47 | Abnormality of purine metabolism (HP:0004352) | 2.79501989 |
| 48 | Malnutrition (HP:0004395) | 2.78381228 |
| 49 | Hypochromic microcytic anemia (HP:0004840) | 2.77090426 |
| 50 | Osteomalacia (HP:0002749) | 2.72194212 |
| 51 | Systemic lupus erythematosus (HP:0002725) | 2.64717153 |
| 52 | Vascular calcification (HP:0004934) | 2.63223299 |
| 53 | Fair hair (HP:0002286) | 2.61652896 |
| 54 | Lethargy (HP:0001254) | 2.54634723 |
| 55 | Abnormal gallbladder morphology (HP:0012437) | 2.53698530 |
| 56 | Dicarboxylic aciduria (HP:0003215) | 2.51806809 |
| 57 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.51806809 |
| 58 | Cholelithiasis (HP:0001081) | 2.48041451 |
| 59 | Hypoglycemic seizures (HP:0002173) | 2.46808378 |
| 60 | Abnormal gallbladder physiology (HP:0012438) | 2.40855884 |
| 61 | Cholecystitis (HP:0001082) | 2.40855884 |
| 62 | Spastic diplegia (HP:0001264) | 2.38585195 |
| 63 | Hydroxyprolinuria (HP:0003080) | 2.38298049 |
| 64 | Abnormality of proline metabolism (HP:0010907) | 2.38298049 |
| 65 | Glomerulonephritis (HP:0000099) | 2.37808309 |
| 66 | Irritability (HP:0000737) | 2.34104548 |
| 67 | Cardiovascular calcification (HP:0011915) | 2.32999880 |
| 68 | Gout (HP:0001997) | 2.30312654 |
| 69 | Purpura (HP:0000979) | 2.28848616 |
| 70 | Amyloidosis (HP:0011034) | 2.28575810 |
| 71 | Mitral stenosis (HP:0001718) | 2.28478096 |
| 72 | Cerebral edema (HP:0002181) | 2.28286783 |
| 73 | Arthropathy (HP:0003040) | 2.24123679 |
| 74 | Hyperphosphaturia (HP:0003109) | 2.20027969 |
| 75 | Late onset (HP:0003584) | 2.19863084 |
| 76 | Pancreatitis (HP:0001733) | 2.19184384 |
| 77 | Esophageal varix (HP:0002040) | 2.18350226 |
| 78 | Neonatal onset (HP:0003623) | 2.17346624 |
| 79 | Sensorimotor neuropathy (HP:0007141) | 2.17294466 |
| 80 | Gingival bleeding (HP:0000225) | 2.07154676 |
| 81 | Brushfield spots (HP:0001088) | 2.06808520 |
| 82 | Menorrhagia (HP:0000132) | 2.06159846 |
| 83 | Reduced antithrombin III activity (HP:0001976) | 2.05735850 |
| 84 | Vomiting (HP:0002013) | 2.04990532 |
| 85 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.04399673 |
| 86 | Abnormality of the gallbladder (HP:0005264) | 2.04208304 |
| 87 | Pulmonary embolism (HP:0002204) | 2.03663003 |
| 88 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.01437086 |
| 89 | Generalized aminoaciduria (HP:0002909) | 2.00603297 |
| 90 | Hemorrhage of the eye (HP:0011885) | 2.00173519 |
| 91 | Enlarged kidneys (HP:0000105) | 1.99246514 |
| 92 | Opisthotonus (HP:0002179) | 1.97572463 |
| 93 | Rickets (HP:0002748) | 1.97381334 |
| 94 | Thrombophlebitis (HP:0004418) | 1.95175391 |
| 95 | * Poikilocytosis (HP:0004447) | 1.94967448 |
| 96 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.92622197 |
| 97 | Proximal tubulopathy (HP:0000114) | 1.91977905 |
| 98 | Abnormality of vitamin metabolism (HP:0100508) | 1.91889411 |
| 99 | Abnormal cartilage morphology (HP:0002763) | 1.90114827 |
| 100 | Glycosuria (HP:0003076) | 1.89199047 |
| 101 | Abnormality of urine glucose concentration (HP:0011016) | 1.89199047 |
| 102 | Abnormality of iron homeostasis (HP:0011031) | 1.89152071 |
| 103 | Hypophosphatemic rickets (HP:0004912) | 1.86983674 |
| 104 | Abnormal urine phosphate concentration (HP:0012599) | 1.86473546 |
| 105 | Renal cortical cysts (HP:0000803) | 1.79469245 |
| 106 | Elevated hepatic transaminases (HP:0002910) | 1.79458830 |
| 107 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.79048447 |
| 108 | Bifid scrotum (HP:0000048) | 1.78843019 |
| 109 | Facial shape deformation (HP:0011334) | 1.78429729 |
| 110 | Potter facies (HP:0002009) | 1.78429729 |
| 111 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.77472699 |
| 112 | Abnormality of alanine metabolism (HP:0010916) | 1.77472699 |
| 113 | Hyperalaninemia (HP:0003348) | 1.77472699 |
| 114 | Nephritis (HP:0000123) | 1.76992652 |
| 115 | Hyperglycemia (HP:0003074) | 1.76064654 |
| 116 | Abnormal tarsal ossification (HP:0008369) | 1.72180448 |
| 117 | Generalized hypopigmentation of hair (HP:0011358) | 1.71842704 |
| 118 | Joint swelling (HP:0001386) | 1.70249155 |
| 119 | Retinal atrophy (HP:0001105) | 1.67925095 |
| 120 | Increased serum pyruvate (HP:0003542) | 1.67336579 |
| 121 | Pigmentary retinal degeneration (HP:0001146) | 1.63176079 |
| 122 | Abnormal biliary tract physiology (HP:0012439) | 1.62869154 |
| 123 | Bile duct proliferation (HP:0001408) | 1.62869154 |
| 124 | Megaloblastic anemia (HP:0001889) | 1.58844579 |
| 125 | Hypothermia (HP:0002045) | 1.58047483 |
| 126 | Gangrene (HP:0100758) | 1.52000347 |
| 127 | Alkalosis (HP:0001948) | 1.51832465 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 6.60859087 |
| 2 | SIK1 | 4.42283468 |
| 3 | FGFR4 | 4.34532121 |
| 4 | ERN1 | 4.33175692 |
| 5 | WNK4 | 3.29112808 |
| 6 | TAOK3 | 3.09363584 |
| 7 | ACVR1B | 2.94176077 |
| 8 | INSRR | 2.88440840 |
| 9 | MST1R | 2.86575015 |
| 10 | ERBB4 | 2.72677793 |
| 11 | FRK | 2.72224720 |
| 12 | PKN2 | 2.20453242 |
| 13 | MAP2K4 | 2.16501095 |
| 14 | STK39 | 2.02761040 |
| 15 | NTRK3 | 2.00321581 |
| 16 | PTK6 | 1.83746336 |
| 17 | MAPK11 | 1.83726196 |
| 18 | TNIK | 1.82280493 |
| 19 | TRIM28 | 1.79268305 |
| 20 | FLT3 | 1.77612630 |
| 21 | PDK2 | 1.73375400 |
| 22 | LATS1 | 1.73052119 |
| 23 | TYK2 | 1.70585459 |
| 24 | GRK6 | 1.67432781 |
| 25 | PIK3CG | 1.64562895 |
| 26 | TRIB3 | 1.54564303 |
| 27 | NLK | 1.47653359 |
| 28 | MAP3K10 | 1.45040171 |
| 29 | BCR | 1.37316000 |
| 30 | WNK3 | 1.34576131 |
| 31 | ABL2 | 1.34198851 |
| 32 | DAPK2 | 1.32965156 |
| 33 | MAP3K7 | 1.30846506 |
| 34 | EIF2AK1 | 1.24094199 |
| 35 | BMPR1B | 1.23614684 |
| 36 | OXSR1 | 1.23326589 |
| 37 | PRKAA2 | 1.22558990 |
| 38 | BRSK2 | 1.21769179 |
| 39 | FGFR2 | 1.21320640 |
| 40 | NEK9 | 1.19798159 |
| 41 | JAK2 | 1.18910656 |
| 42 | CASK | 1.18161421 |
| 43 | KDR | 1.17763433 |
| 44 | CAMKK2 | 1.17298187 |
| 45 | TBK1 | 1.13573569 |
| 46 | ERBB2 | 1.13165869 |
| 47 | FGFR1 | 1.08995326 |
| 48 | MET | 1.08921054 |
| 49 | RIPK1 | 1.05018980 |
| 50 | ADRBK2 | 1.03806168 |
| 51 | SGK494 | 0.98464014 |
| 52 | SGK223 | 0.98464014 |
| 53 | FER | 0.97551043 |
| 54 | MAPK4 | 0.95715279 |
| 55 | EPHB1 | 0.94450438 |
| 56 | MAP3K14 | 0.94324220 |
| 57 | JAK1 | 0.93755991 |
| 58 | MAP2K3 | 0.93621253 |
| 59 | MAP2K6 | 0.92201390 |
| 60 | MAP3K11 | 0.91377602 |
| 61 | IRAK1 | 0.91186568 |
| 62 | PRKCZ | 0.90270272 |
| 63 | MAP3K3 | 0.89540809 |
| 64 | PINK1 | 0.87282196 |
| 65 | AKT3 | 0.85736846 |
| 66 | MAP3K12 | 0.83582571 |
| 67 | MAP4K2 | 0.81447295 |
| 68 | CDK6 | 0.81258110 |
| 69 | MAPK15 | 0.80728608 |
| 70 | PRKG1 | 0.76242700 |
| 71 | PRKACA | 0.75677411 |
| 72 | PRKACG | 0.74922069 |
| 73 | CSK | 0.74494914 |
| 74 | DYRK1B | 0.73962611 |
| 75 | STK38L | 0.73721678 |
| 76 | EPHA3 | 0.70518190 |
| 77 | CSNK1E | 0.70483346 |
| 78 | SGK1 | 0.69631653 |
| 79 | IRAK3 | 0.69288748 |
| 80 | PRKAA1 | 0.68719328 |
| 81 | PTK2 | 0.68198650 |
| 82 | CSNK1D | 0.67820938 |
| 83 | CAMK2G | 0.66742350 |
| 84 | MAPK12 | 0.65280178 |
| 85 | GSK3A | 0.63777280 |
| 86 | MAP2K2 | 0.62355104 |
| 87 | EIF2AK3 | 0.61068553 |
| 88 | CAMK1D | 0.60439465 |
| 89 | SGK3 | 0.58784027 |
| 90 | PRKG2 | 0.58493363 |
| 91 | PRKCE | 0.58330387 |
| 92 | MAPKAPK3 | 0.56482796 |
| 93 | PDPK1 | 0.56470674 |
| 94 | MAP3K2 | 0.55229946 |
| 95 | TIE1 | 0.55222739 |
| 96 | IKBKE | 0.54400077 |
| 97 | FGFR3 | 0.54182147 |
| 98 | DYRK2 | 0.54035923 |
| 99 | RPS6KB1 | 0.52748162 |
| 100 | GRK1 | 0.52490546 |
| 101 | PRKCQ | 0.52391722 |
| 102 | TRPM7 | 0.50975654 |
| 103 | NUAK1 | 0.49676612 |
| 104 | MAP3K4 | 0.49442890 |
| 105 | ZAK | 0.49311827 |
| 106 | MAP2K1 | 0.48256681 |
| 107 | ICK | 0.47793004 |
| 108 | MAPK7 | 0.47010083 |
| 109 | STK24 | 0.46336327 |
| 110 | TAOK2 | 0.45621198 |
| 111 | PBK | 0.45381222 |
| 112 | CSF1R | 0.43812375 |
| 113 | CSNK2A1 | 0.43692165 |
| 114 | PRKACB | 0.43595875 |
| 115 | TGFBR2 | 0.43425440 |
| 116 | RPS6KA3 | 0.42612190 |
| 117 | EPHA2 | 0.42524651 |
| 118 | PRKCB | 0.42116095 |
| 119 | MAP3K1 | 0.41694252 |
| 120 | EPHA4 | 0.41644959 |
| 121 | MATK | 0.41549850 |
| 122 | IGF1R | 0.41170017 |
| 123 | CSNK1G1 | 0.41066056 |
| 124 | CSNK2A2 | 0.41014862 |
| 125 | MAP3K5 | 0.40595447 |
| 126 | RET | 0.39698176 |
| 127 | NEK6 | 0.39490661 |
| 128 | TYRO3 | 0.38703410 |
| 129 | CSNK1A1 | 0.37757569 |
| 130 | CDK4 | 0.37355117 |
| 131 | MAP3K13 | 0.36330934 |
| 132 | MAPK13 | 0.35540234 |
| 133 | PDK1 | 0.35391786 |
| 134 | EPHB2 | 0.35108769 |
| 135 | MINK1 | 0.34660218 |
| 136 | BMX | 0.34507275 |
| 137 | PIK3CA | 0.33223290 |
| 138 | SRC | 0.31313400 |
| 139 | SGK2 | 0.31126148 |
| 140 | PRKCA | 0.30258523 |
| 141 | MTOR | 0.29207572 |
| 142 | EGFR | 0.29091792 |
| 143 | LMTK2 | 0.28530192 |
| 144 | MAP3K6 | 0.26782706 |
| 145 | CAMK4 | 0.25555358 |
| 146 | PRKCG | 0.23435250 |
| 147 | PAK3 | 0.22041406 |
| 148 | CSNK1G2 | 0.20175081 |
| 149 | ABL1 | 0.19094027 |
| 150 | PDK3 | 0.18496143 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.28577870 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.50374271 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.43528139 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.21091765 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.04093597 |
| 6 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.70348046 |
| 7 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.63680817 |
| 8 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.56372013 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.51183285 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.47483113 |
| 11 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.39584206 |
| 12 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.30432929 |
| 13 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.29018023 |
| 14 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.19157092 |
| 15 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.07844767 |
| 16 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.07178103 |
| 17 | Peroxisome_Homo sapiens_hsa04146 | 2.01478974 |
| 18 | Histidine metabolism_Homo sapiens_hsa00340 | 2.00006413 |
| 19 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.95729958 |
| 20 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.95099311 |
| 21 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.92129034 |
| 22 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.91459634 |
| 23 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.82659210 |
| 24 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.82076456 |
| 25 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.75876690 |
| 26 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.73963502 |
| 27 | Retinol metabolism_Homo sapiens_hsa00830 | 1.72553900 |
| 28 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.69572609 |
| 29 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.64881701 |
| 30 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.62427391 |
| 31 | * Fat digestion and absorption_Homo sapiens_hsa04975 | 1.57950172 |
| 32 | * Bile secretion_Homo sapiens_hsa04976 | 1.56490024 |
| 33 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.52920066 |
| 34 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.52347581 |
| 35 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.51623891 |
| 36 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.50441504 |
| 37 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.49794793 |
| 38 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.43468165 |
| 39 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.39907425 |
| 40 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.37837076 |
| 41 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.36170821 |
| 42 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.35975907 |
| 43 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.25611037 |
| 44 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.22354001 |
| 45 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.22311536 |
| 46 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.16755551 |
| 47 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.15148056 |
| 48 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.14478784 |
| 49 | * ABC transporters_Homo sapiens_hsa02010 | 1.11762057 |
| 50 | Carbon metabolism_Homo sapiens_hsa01200 | 1.11660684 |
| 51 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.06569844 |
| 52 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.01709756 |
| 53 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.99955968 |
| 54 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.99023257 |
| 55 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.96924145 |
| 56 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.93132749 |
| 57 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.90004735 |
| 58 | Sulfur relay system_Homo sapiens_hsa04122 | 0.84783330 |
| 59 | Lysine degradation_Homo sapiens_hsa00310 | 0.80825052 |
| 60 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.78362203 |
| 61 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.78101398 |
| 62 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.74224402 |
| 63 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.73000397 |
| 64 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.63678104 |
| 65 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.58234185 |
| 66 | Galactose metabolism_Homo sapiens_hsa00052 | 0.53069293 |
| 67 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.52935364 |
| 68 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.52328851 |
| 69 | Metabolic pathways_Homo sapiens_hsa01100 | 0.46199475 |
| 70 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.38947782 |
| 71 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.31245362 |
| 72 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.27799936 |
| 73 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.26261404 |
| 74 | Prion diseases_Homo sapiens_hsa05020 | 0.24317078 |
| 75 | Insulin resistance_Homo sapiens_hsa04931 | 0.23369250 |
| 76 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.22045886 |
| 77 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.19656938 |
| 78 | Pertussis_Homo sapiens_hsa05133 | 0.19011960 |
| 79 | Other glycan degradation_Homo sapiens_hsa00511 | 0.13814474 |
| 80 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.12583827 |
| 81 | Mineral absorption_Homo sapiens_hsa04978 | 0.11489290 |
| 82 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.09968863 |
| 83 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.09833055 |
| 84 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.07327470 |
| 85 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.06749857 |
| 86 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.02254281 |
| 87 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.00785971 |
| 88 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.00706966 |
| 89 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.2283525 |
| 90 | Bladder cancer_Homo sapiens_hsa05219 | -0.2214572 |
| 91 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.2194499 |
| 92 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.2182067 |
| 93 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.2144002 |
| 94 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.2091795 |
| 95 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1983177 |
| 96 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1592450 |
| 97 | Protein export_Homo sapiens_hsa03060 | -0.1589391 |
| 98 | Hepatitis C_Homo sapiens_hsa05160 | -0.1545631 |
| 99 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1421482 |
| 100 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1294923 |
| 101 | Circadian rhythm_Homo sapiens_hsa04710 | -0.1210838 |
| 102 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1173197 |
| 103 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | -0.1149454 |
| 104 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1138209 |
| 105 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1114364 |
| 106 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0826583 |
| 107 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.0613320 |
| 108 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0550188 |
| 109 | Serotonergic synapse_Homo sapiens_hsa04726 | -0.0234158 |

